Could cannabis compound calm Alzheimer's agitation?
NCT ID NCT06014424
Summary
This study is testing whether CBD (cannabidiol) capsules can help reduce agitation in people with Alzheimer's disease. Forty participants will try both CBD and a placebo pill in a random order over 19 weeks to see which works better. Researchers will measure changes in agitation, caregiver stress, thinking skills, and overall behavior.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre for Addiction and Mental Health
RECRUITINGToronto, Ontario, Canada
Contact Email: •••••@•••••
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ontario Shores Centre for Mental Health Sciences
RECRUITINGWhitby, Ontario, L1N 5S9, Canada
Contact Email: •••••@•••••
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M3H0A7, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Calgary
RECRUITINGCalgary, Alberta, T2N 4N1, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.